‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds Sarah Speight.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

WIPR at CIPA: Unified Patent Court high fliers gather in Edinburgh

‘Like the EPO on steroids’: Life at the UPC coalface

Crocs dismisses ‘patent lie’ claims as ‘meritless’ after court revives rival’s false advertising case

Lululemon's bid to pause ‘Flyknit’ dispute with Nike denied

Court decries Panasonic’s ‘illegitimate’ SEP actions

Seasonal products and genuine trademark use in the EU

German court convicts three people of fraud over ‘misleading’ IP invoices

From breaking barriers to sharing best practice: Themes from Marques

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

More on this story

Editor's picks

Editor's picks

More articles